PEDIATRICS Vol. 108 No. 3 September 2001, pp. 735-740
Improving Management of Diabetic Ketoacidosis in Children
Received Dec 20, 2000; accepted Mar 9, 2001.
From the * Department of Pediatrics, Division of Endocrinology,
University of Texas Southwestern Medical Center, Dallas, Texas.
Objective. The optimal fluid
management for diabetic ketoacidosis (DKA) is uncertain. In an effort
to simplify DKA therapy, we revised the treatment protocol in our
institution to use a simpler method of calculating fluid needs, use
fluids with higher sodium concentration, and allow glucose
concentration to be adjusted easily. We performed a retrospective study
to determine the effects of these revisions.
Design. We compared patients treated with traditional and
revised protocols (~220 and ~300 patients, respectively, over
consecutive 2.75-year intervals). Sixty patient records were randomly
selected from the first group (30 treated with each of 2 protocol
versions) and 30 from the second group. Biochemical and clinical
parameters were analyzed.
Results. Patients selected for detailed analysis were
similar in demographics and initial laboratory measurements. Patients
treated under the revised fluid protocol received less total fluid,
needed fewer intravenous fluid changes, were treated at less cost, and resolved acidosis more rapidly than patients treated under the original
protocols. The rate of cerebral edema (0.3%-0.5%) was unchanged.
Conclusion. A DKA protocol that necessitates less fluid
delivery and fewer calculations simplifies therapy and is associated
with more rapid correction of acidosis.
This article has been cited by other articles:
![]() |
P. B. Koul Diabetic Ketoacidosis: A Current Appraisal of Pathophysiology and Management Clinical Pediatrics, March 1, 2009; 48(2): 135 - 144. [Abstract] [PDF] |
||||
![]() |
E. C. Kaizer, C. L. Glaser, D. Chaussabel, J. Banchereau, V. Pascual, and P. C. White Gene Expression in Peripheral Blood Mononuclear Cells from Children with Diabetes J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3705 - 3711. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wolfsdorf, N. Glaser, and M. A. Sperling Diabetic Ketoacidosis in Infants, Children, and Adolescents: A consensus statement from the American Diabetes Association Diabetes Care, May 1, 2006; 29(5): 1150 - 1159. [Full Text] [PDF] |
||||
![]() |
T B Brown Cerebral oedema in childhood diabetic ketoacidosis: Is treatment a factor? Emerg. Med. J., March 1, 2004; 21(2): 141 - 144. [Abstract] [Full Text] [PDF] |
||||
![]() |
D B Dunger, M A Sperling, C L Acerini, D J Bohn, D Daneman, T P A Danne, N S Glaser, R Hanas, R L Hintz, L L Levitsky, et al. ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents Arch. Dis. Child., February 1, 2004; 89(2): 188 - 194. [Abstract] [Full Text] |
||||
![]() |
D. B. Dunger, M. A. Sperling, C. L. Acerini, D. J. Bohn, D. Daneman, T. P.A. Danne, N. S. Glaser, R. Hanas, R. L. Hintz, L. L. Levitsky, et al. European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society Consensus Statement on Diabetic Ketoacidosis in Children and Adolescents Pediatrics, February 1, 2004; 113(2): e133 - 140. [Full Text] [PDF] |
||||
![]() |
A P C P Carlotti, D Bohn, and M L Halperin Importance of timing of risk factors for cerebral oedema during therapy for diabetic ketoacidosis Arch. Dis. Child., February 1, 2003; 88(2): 170 - 173. [Abstract] [Full Text] [PDF] |
||||










